A S Senatorova

Learn More
RATIONALE Arikace is a liposomal amikacin preparation for aerosol delivery with potent Pseudomonas aeruginosa killing and prolonged lung deposition. OBJECTIVES To examine the safety and efficacy of 28 days of once-daily Arikace in cystic fibrosis (CF) patients chronically infected with P aeruginosa. METHODS 105 subjects were evaluated in double-blind,(More)
114 obese (BMI > 97th age-sex percentile) and 27 overweight (BMI 85-97th age-sex percentile) adolescents (10-18 years) were studied using tissue Doppler echocardiography for the assessment of the geometry of the left ventricle and it's systolic and diastolic functions. Subjects were age and sex matched and grouped according to BMI: + 1-2 SD (Group 1); + 2-3(More)
  • 1